Deans' stroke musings: Neuralstem Gets Approval To Commence Ischemic Stroke Trial In China

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 27, 2012

Neuralstem Gets Approval To Commence Ischemic Stroke Trial In China

Read this on stem cells first;

Stem Cell Fraud: A 60 Minutes investigation

http://www.nasdaq.com/article/neuralstem-gets-approval-to-commence-ischemic-stroke-trial-in-china-20120927-00705
Neuralstem, Inc. (CUR), Thursday said it was granted approval to commence a clinical trial, through its subsidiary, Neuralstem China, to treat motor deficits due to ischemic strokes with its spinal cord stem cells NSI-566 at BaYi Brain Hospital, in Beijing, China.
The approved trial will include a combined phase I/II design and will witness direct injections of NSI-566 cells into the brain. The trial is expected to begin early next year.
Ischemic strokes, one of the most common type of strokes, occur as a result of an obstruction within a blood vessel supplying blood to the brain.